Insiders Updates
ESPR shares expected to outperform in the next 12 months
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Esperion Therapeutics Inc’s recent filing unveils that its General Counsel Looker Benjamin unloaded Company’s shares for reported $1470.0 on Jul
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Esperion Therapeutics Inc’s recent filing unveils that its General Counsel Looker Benjamin unloaded Company’s shares for reported $1470.0 on Jul
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Esperion Therapeutics Inc’s recent filing unveils that its General Counsel Looker Benjamin unloaded Company’s shares for reported $7398.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Esperion Therapeutics Inc revealed its General Counsel Looker Benjamin unloaded Company’s shares for reported $7398.0 on Jun
Esperion Therapeutics Inc’s recently made public that its General Counsel Looker Benjamin unloaded Company’s shares for reported $7398.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or